AIDS Related Lymphoma
generalAn aggressive lymphoma that develops in HIV-positive patients. There is a significant increase in the incidence of lymphomas associated with the AIDS epidemic. These lymphomas are usually extranodal, most often express a B-cell phenotype and morphologically are classified as Burkitt, diffuse large B-cell, and Hodgkin lymphomas. The prognosis is closely related to the severity of immunodeficiency.
18
Centers
12
Active Trials
—
Cancer Funding
Top Centers for AIDS Related Lymphoma(18)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 60.3 |
| 2 | NCI Comprehensive Active Research Program | 60.3 |
| 3 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 60.3 |
| 4 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 60.3 |
| 5 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive Active Research Program | 60.3 |
| 6 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 60.3 |
| 7 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 60.3 |
| 8 | NCI Clinical Active Research Program | 60.3 |
| 9 | University of Illinois Cancer CenterChicago, IL Active Research Program | 60.3 |
| 10 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive Active Research Program | 60.3 |
| 11 | Boston University Cancer CenterBoston, MA Active Research Program | 60.3 |
| 12 | Cancer Center at IllinoisUrbana, IL Active Research Program | 60.3 |
| 13 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive | 37.8 |
| 14 | NCI Comprehensive | 37.8 |
| 15 | NCI Comprehensive | 37.8 |
| 16 | Moffitt Cancer CenterTampa, FL NCI Comprehensive | 37.8 |
| 17 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive | 37.8 |
| 18 | 37.8 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →